Deer Management Company’s Kymera Therapeutics KYMR Stock Holding History

Deer Management Company’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.4M	Hold	125,895	–	–	1.78%	6
2026 Q1	$10.5M	Sell	125,895 -104,916	-45%	-$8.31M	1.69%	5
2025 Q4	$18M	Sell	230,811 -95,084	-29%	-$6.42M	1.75%	4
2025 Q3	$18.4M	Hold	325,895	–	–	1.65%	4
2025 Q2	$14.2M	Sell	325,895 -90,000	-22%	-$3.1M	1.13%	5
2025 Q1	$11.4M	Hold	415,895	–	–	1.05%	5
2024 Q4	$16.7M	Hold	415,895	–	–	1.31%	6
2024 Q3	$19.7M	Hold	415,895	–	–	3.12%	5
2024 Q2	$12.4M	Hold	415,895	–	–	2.55%	8
2024 Q1	$16.7M	Sell	415,895 -200,000	-32%	-$7.16M	3.03%	8
2023 Q4	$15.7M	Hold	615,895	–	–	2.03%	7
2023 Q3	$8.56M	Hold	615,895	–	–	1.04%	9
2023 Q2	$14.2M	Hold	615,895	–	–	1.27%	9
2023 Q1	$18.2M	Hold	615,895	–	–	1.67%	8
2022 Q4	$15.4M	Hold	615,895	–	–	1.42%	11
2022 Q3	$13.4M	Hold	615,895	–	–	0.94%	11
2022 Q2	$12.1M	Hold	615,895	–	–	0.78%	11
2022 Q1	$26.1M	Hold	615,895	–	–	0.9%	11
2021 Q4	$39.1M	Buy	+615,895	New	+$35.9M	1%	10

Other funds holding KYMR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Deer Management Company's KYMR Position: Q2 2026 in Review

Deer Management Company held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 125,895 shares worth $14.4M. The position accounts for 1.78% of the portfolio, ranked #6.

Deer Management Company first reported a position in KYMR in Q4 2021 and has held it in 19 quarters since. The position peaked at $39.1M in Q4 2021. 274 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

Deer Management Company held 125,895 shares of Kymera Therapeutics worth $14.4M as of Q2 2026.
Deer Management Company left its Kymera Therapeutics share count unchanged in Q2 2026.
Kymera Therapeutics made up 1.78% of Deer Management Company's portfolio in Q2 2026, its #6 holding.
Deer Management Company first reported a position in Kymera Therapeutics in Q4 2021 and has held it in 19 quarters since.
Deer Management Company's Kymera Therapeutics position peaked at $39.1M in Q4 2021.
274 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Deer Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.